SCHEMBL1979080

SCHEMBL1979080

NC(Cc1ccc(OP(=O)(O)O)c(CF)c1)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.47
PPARG P37231 1/20 0.47
AGTR2 P50052 1/20 0.47
MEN1 O00255 1/20 0.47
BLM P54132 1/20 0.47
KMT2A Q03164 1/20 0.47
PTPN1 P18031 3/20 0.47
SLC7A5 Q01650 4/20 0.47
PTGS1 P23219 2/20 0.47
KDM4E B2RXH2 1/20 0.47
USP2 O75604 1/20 0.47
EGFR P00533 1/20 0.47
LCK P06239 1/20 0.47
FYN P06241 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
ALOX15 P16050 1/20 0.47
HTR2A P28223 1/20 0.47
PTGS2 P35354 1/20 0.47
RECQL P46063 1/20 0.47
HIF1A Q16665 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19712218 0.88 NR1I2 (0.48) NR1I2PPARGAGTR2MEN1BLM
SCHEMBL19712217 0.88 NR1I2 (0.48) NR1I2PPARGAGTR2MEN1BLM
SCHEMBL17695712 0.85 SLC7A5 (0.53) NR1I2PPARGAGTR2MEN1BLM
Foslevodopa SCHEMBL17685899 0.83 SLC7A5 (0.61) NR1I2PPARGAGTR2MEN1BLM
Foslevodopa SCHEMBL29927312 0.83 SLC7A5 (0.61) NR1I2PPARGAGTR2MEN1BLM
Foslevodopa SCHEMBL17685900 0.83 SLC7A5 (0.61) NR1I2PPARGAGTR2MEN1BLM
SCHEMBL1979929 0.82 NR1I2 (0.47) NR1I2PPARGAGTR2MEN1BLM
SCHEMBL13021158 0.82 NR1I2 (0.41) NR1I2PPARGAGTR2MEN1BLM
SCHEMBL14060980 0.82 PTPRC (0.50) NR1I2PPARGAGTR2MEN1BLM
SCHEMBL9108309 0.80 SLC7A5 (0.61) NR1I2PPARGAGTR2MEN1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8445706-B2 Unnatural amino acids capable of covalently modifying protein phosphatases and their use as general and specific inhibitors and probes BOARD OF TRUSTEES OF NORTHERN ILLINOIS UNIVERSITY (US) 2013-05-21 US claimed
US-20100061936-A1 UNNATURAL AMINO ACIDS CAPABLE OF COVALENTLY MODIFYING PROTEIN PHOSPHATASES AND THEIR USE AS GENERAL AND SPECIFIC INHIBITORS AND PROBES BOARD OF TRUSTEES OF NORTHERN ILLINOIS UNIVERSITY 2010-03-11 US claimed
EP-2509990-A1 NOVEL PHOSPH(ON)ATE- AND SULF(ON)ATE-BASED PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2012-10-17 EP disclosed
US-20120245029-A1 NOVEL PHOSPH(ON)ATE- AND SULF(ON)ATE-BASED PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2012-09-27 US disclosed
WO-2011069688-A1 NOVEL PHOSPH(ON)ATE- AND SULF(ON)ATE-BASED PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2011-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120245029-A1 NOVEL PHOSPH(ON)ATE- AND SULF(ON)ATE-BASED PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS TYMP, PNP, MTAP NR1I2 4261/4885PPARG 1663/4885AGTR2 1320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.